Adage Capital Partners Gp, L.L.C. Cara Therapeutics, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$12.38 - $29.19 $2.17 Million - $5.11 Million	-175,153 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$15.07 - $21.71 $2.64 Million - $3.8 Million	175,153 New	175,153 $3.8 Million
Q1 2020 May 15, 2020	SELL	$9.12 - $17.78 $2.8 Million - $5.46 Million	-307,000 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$16.11 - $25.98 $3.22 Million - $5.2 Million	-200,000 Reduced 39.45%	307,000 $4.95 Million
Q3 2019 Nov 14, 2019	BUY	$18.28 - $26.91 $9.27 Million - $13.6 Million	507,000 New	507,000 $9.27 Million

826K

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $257M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.